Our Technology

Snowdon's Discovery Platform
Snowdon provides a unique solution to the problems of efficiency and productivity in drug discovery by integrating an array of advanced tools with proprietary information technology to more efficiently discover new drugs and harness the flood of new disease-related protein targets presented by genomics. We believe that our technologies offer an attractive solution to the resource and productivity dilemmas facing drug discovery.

Overview of Snowdon’s Discovery Platform

click for larger image

Snowdon employs computational tools as key elements of drug discovery to maximize cost and time efficiency and increase our success rate. Our discovery platform accelerates the identification of prospective drug candidates starting from the very beginning of the project. We employ an integrated array of proprietary computational tools that help us to select high-value molecules from our in silico library of 5+ million of vendor-available compounds that can be readily acquired in small quantities for initial biological "proof of concept" studies. In silico filters are implemented to select only the most promising hits for further consideration. This approach allows rapid progression from "hit" to "lead" in the drug discovery process, and enables us to quickly generate prospective drug candidates.

Computational Tools for Assessing Product Quality and Safety
Snowdon employs its expertise in statistics, chemometrics, and pattern recognition to assist partner organizations to solve problems in product quality and safety. This is accomplished by transforming complex analytical data obtained from chromatographic and spectroscopic experiments on food, pharmaceutical, and other consumer products into simple computational models for data visualization, classification, and prediction. These models have become indispensable tools for issues in product quality assurance. [more...]

home | therapeutic areas | our technology | about us | news | employment | contact us